| Name | 4-(4-morpholin-4-ylbutylsulfanyl)phenol |
|---|---|
| Synonyms |
4-(4-Morpholin-4-yl-butylsulfanyl)-phenol
4-{[4-(4-Morpholinyl)butyl]sulfanyl}phenol Phenol, 4-[[4-(4-morpholinyl)butyl]thio]- 4-(4-(4-hydroxyphenylthio)butyl)morpholine p-Hydroxyphenyl-4-morpholinobutylsulfid MoTP 4-(4-Morpholinobutylthio)phenol |
| Description | MoTP is a specific platelet activating factor receptor antagonist and can induce melanocyte ablation. MoTP can be used for the research of cancer. |
|---|---|
| Related Catalog |
| Density | 1.2±0.1 g/cm3 |
|---|---|
| Boiling Point | 424.9±40.0 °C at 760 mmHg |
| Molecular Formula | C14H21NO2S |
| Molecular Weight | 267.387 |
| Flash Point | 210.8±27.3 °C |
| Exact Mass | 267.129303 |
| PSA | 58.00000 |
| LogP | 1.98 |
| Vapour Pressure | 0.0±1.0 mmHg at 25°C |
| Index of Refraction | 1.595 |
| RIDADR | NONH for all modes of transport |
|---|
|
~%
Detail
|
| Literature: The Dow Chemical Company Patent: US4134996 A1, 1979 ; |
| Precursor 4 | |
|---|---|
| DownStream 0 | |